VACCINE AGAINST VIRAL HEMORRHAGIC DISEASE IN RABBITS

FIELD: veterinary medicine. SUBSTANCE: the suggested vaccine contains as an antigen a 10-15%-hepatic suspension of rabbits died after infection by virulent viral strain of viral hemorrhagic disease in rabbits isolated out of local epizootic focus upon physiological solution (pH 7.2), theotropin, alu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SHEVCHENKO A.A, ZERKALEV D.JU, GNEZDILOV I.D, SHEVCHENKO L.V, GOLENSKIJ A.G, KRUZHNOV N.N
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: veterinary medicine. SUBSTANCE: the suggested vaccine contains as an antigen a 10-15%-hepatic suspension of rabbits died after infection by virulent viral strain of viral hemorrhagic disease in rabbits isolated out of local epizootic focus upon physiological solution (pH 7.2), theotropin, alumopotash alum at the following ratio of components, weight%: rabbits' hepatic suspension 98.1-98.6, theotropin 0.3-0.4, alumopotash alum 1.0-1.5. The suggested vaccine is of high immunogenicity and safe. EFFECT: higher efficiency. 5 ex, 1 tbl